Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03441659 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ACL Reconstruction: Clinical Outcome

Study acronym: RIC-ACL
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Lead sponsor: Istituto Ortopedico Rizzoli to Stefano Zaffagniniv5
  3. 2 versions Re-verified since May 27, 2024, no change to tracked fieldsv3-v4
  4. Primary and study completion dates: Nov 1, 2022 to Dec 2030
    • Start date: Nov 1, 2017 to Dec 17, 2020
    • Secondary endpoints: details revised at 5 of 5 entries
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is intended to include all patients who will undergo surgical reconstruction of the anterior cruciate ligament (ACL). The patients will be monitored and evaluated preoperatively and also at 6 months and 1, 2 and 5 years after the intervention through a clinical visit or telephone interview. Such assessments will include the administration of questionnaires to determine the patient's functional symptoms and the objective examination of the knee during a medical examination to quantify its stability.
Trial Details
NCT Number NCT03441659
Lead Sponsor Stefano Zaffagnini
Conditions
(from sponsor)		 ACL Injury
Related terms Anterior Cruciate Ligament Injuries
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov